Stockreport

Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin

Enzo Biochem, Inc. ($0.01 Par Value)  (ENZ) 
Last enzo biochem, inc. ($0.01 par value) earnings: 12/7 04:10 pm Check Earnings Report
US:NYSE Investor Relations: enzo.com/corporate/investor-information
PDF NEW YORK, NY, May 12, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc.  (NYSE: ENZ) a leading biosciences and diagnostics company, today announced the recent issuance of U. [Read more]